Cover Image
市場調查報告書

脊椎用生技藥品的全球市場:2016∼2020年

Global Spine Biologics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361428
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
脊椎用生技藥品的全球市場:2016∼2020年 Global Spine Biologics Market 2016-2020
出版日期: 2016年06月08日 內容資訊: 英文 79 Pages
簡介

全球脊椎用生技藥品市場,這幾年達成理想的成長。高齡化和脊椎疾病的發病率上升等成為市場促進的推動力。預計全球脊椎用生技藥品市場,2016∼2020年,以年複合成長率2.07%擴大。

本報告提供全球脊椎用生技藥品市場現狀與2020年預測,市場規模與銷售趨勢,主要供應商的競爭環境與簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 脊椎用生技藥品:概要

  • 脊椎手術的生技藥品的臨床性需求
  • 對脊椎用生技藥品的資金
  • 臨床實驗中的產品

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

  • 異體移植片
  • 幹細胞
  • BMP
  • DBM
  • 合成骨移植

第8章 全球異體移植片的脊椎用生技藥品市場

第9章 全球幹細胞的脊椎用生技藥品市場

第10章 全球BMP的脊椎用生技藥品市場

第11章 全球DBM的脊椎用生技藥品市場

第12章 全球合成骨移植的脊椎用生技藥品市場

第13章 各地區市場區隔

  • 歐洲、中東、非洲
  • 亞太地區

第14章 主要國家

  • 美國
  • 日本
  • 德國

第15章 推動市場的要素

第16章 促進要素的影響

第17章 市場課題

第18章 促進要素與課題的影響

第19章 市場趨勢

第20章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • Medtronic
  • Johnson & Johnson
  • Stryker
  • NuVasive
  • Zimmer Biomet
  • SeaSpine
  • 其他值得注意的供應商

第21章 附錄

第22章 關於Technavio

目錄
Product Code: IRTNTR9386

About the Spine Biologics Market

The global spine biologics market has seen an ideal shift in the past few years. The market is witnessing growth because of the developments and adoption of spine biologic by end-users.

The market is driven by factors such as the increase in older adult population and growing incidence of spinal disorders such as herniated discs, degenerative disc disease, spondylolisthesis, prolapsed intervertebral disc, and spinal stenosis. A shift in preference for MI surgeries over open surgeries has led to the development of technologically advanced spinal implants, which leads to an increased demand for spine biologics. An increasing number of lumbar fusion procedures being performed, and rising popularity among the younger and active patient population to retain some movement and flexibility, are some of the trends currently being witnessed in the market.

Technavio's analysts forecast the global spine biologics market to grow at a CAGR of 2.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global spine biologics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of the following:

  • Allograft
  • Stem cells
  • Bone morphogenetic proteins (BMPs)
  • Demineralized bone matrix (DBM)
  • Synthetic bone grafts

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Spine Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Medtronic
  • Johnson & Johnson
  • Stryker
  • NuVasive
  • Zimmer Biomet
  • SeaSpine

Other Prominent Vendors

  • Alphatec Spine
  • AMEDICA
  • Anika Therapeutics
  • Arthrex
  • Baxter
  • Berkeley Advanced Biomaterial
  • Biomimetic Therapeutics
  • Globus Medical
  • Integra Life Sciences
  • ISTO Technologies
  • K2M
  • LDR
  • Orthofix International
  • RTI Surgical
  • Xtant Medical

Market driver

  • Growing popularity of MI spinal and robot-assisted surgeries
  • For a full, detailed list, view our report

Market challenge

  • Complications associated with spine implants in spine surgeries
  • For a full, detailed list, view our report

Market trend

  • Emerging MI sacroiliac joint fusion technique
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Spine biologics: An overview

  • Clinical need for biologics in spine surgeries
  • Funding in spine biologics
  • Spine biologic products under clinical trials

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product

  • Allograft
  • Stem cells
  • BMP
  • DBM
  • Synthetic bone grafts

PART 08: Global spine biologics market by allograft

  • Market size and forecast

PART 09: Global spine biologics market by stem cells

  • Market overview
  • Market size and forecast

PART 10: Global spine biologics market by BMP

  • Market overview

PART 11: Global spine biologics market by DBM

  • Market overview
  • Market size and forecast

PART 12: Global spine biologics market by synthetic bone grafts

  • Market overview

PART 13: Geographical segmentation

  • Spine biologics market in Americas
  • Spine biologics market in EMEA
  • Spine biologics market in APAC

PART 14: Key leading countries

  • US
  • Japan
  • Germany

PART 15: Market drivers

  • Increased incidence of spinal disorders
  • Growing popularity of MI spinal and robot-assisted surgeries
  • Rise in strategic partnerships for marketing
  • Increase in older population

PART 16: Impact of drivers

PART 17: Market challenges

  • Complications associated with spine implants in surgeries
  • Stringent regulatory and reimbursement policies
  • High cost of spinal fusion surgery
  • Intense competition
  • Poor performance of bone graft substitute

PART 18: Impact of drivers and challenges

PART 19: Market trends

  • Advances in technology
  • Rise in popularity of physician-owned ASCs
  • Emerging MI sacroiliac joint fusion technique
  • Product development in collaboration with research institutes
  • Increase in M&A

PART 20: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Medtronic
  • Johnson & Johnson
  • Stryker
  • NuVasive
  • Zimmer Biomet
  • SeaSpine
  • Other prominent vendors

PART 21: Appendix

  • List of abbreviations

PART 22: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Spine fusion techniques
  • Exhibit 03: Funding for development of spine biologics
  • Exhibit 04: List of spine biologic products under clinical trials
  • Exhibit 05: Spine market model 2015
  • Exhibit 06: Global spine biologics market 2015-2020 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Segmentation of global spine biologics market by product type
  • Exhibit 09: Global spine biologics market segmentation by product type 2015
  • Exhibit 10: Global spine biologics market by allografts 2015-2020 ($ millions)
  • Exhibit 11: Global spine biologics market by stem cells 2015-2020 ($ millions)
  • Exhibit 12: Global spine biologics market by BMP 2015-2020 ($ millions)
  • Exhibit 13: Global spine biologics market by DBM 2015-2020 ($ millions)
  • Exhibit 14: Global spine biologics market by synthetic bone grafts 2015-2020 ($ millions)
  • Exhibit 15: Segmentation of global spine biologics market by product type 2015-2020 ($ millions)
  • Exhibit 16: Segmentation of global spine biologics market by product type 2015-2020 (%)
  • Exhibit 17: Global spine biologics market by geography 2015
  • Exhibit 18: Global spine biologics market by geography 2020
  • Exhibit 19: Spine biologics market in Americas 2015-2020 ($ billions)
  • Exhibit 20: Spine biologics market in EMEA 2015-2020 ($ millions)
  • Exhibit 21: Spine biologics market in APAC 2015-2020 ($ millions)
  • Exhibit 22: Global spine biologics market by geography 2015-2020 ($ millions)
  • Exhibit 23: Global spine biologics market by geography 2015-2020
  • Exhibit 24: Population aged 60 years and above: World, developed, and developing regions 1950-2050 (millions)
  • Exhibit 25: Impact of drivers
  • Exhibit 26: Comparison of the cost of spine surgeries 2015
  • Exhibit 27: Impact of drivers and challenges
  • Exhibit 28: Ranking of top six vendors 2015
  • Exhibit 29: Market share of vendors 2015
  • Exhibit 30: Collaboration between vendors and universities or organizations
  • Exhibit 31: Medtronic: Product portfolio
  • Exhibit 32: Medtronic: Restorative Therapies group by revenue 2013-2015 ($ billions)
  • Exhibit 33: Medtronic: Key takeaways
  • Exhibit 34: Johnson & Johnson: Product portfolio
  • Exhibit 35: Johnson & Johnson: Key takeaways
  • Exhibit 36: Stryker: Product portfolio
  • Exhibit 37: Stryker: Orthopedics segment by revenue 2013-2015 ($ billions)
  • Exhibit 38: Stryker: Key takeaways
  • Exhibit 39: NuVasive: Product portfolio
  • Exhibit 40: NuVasive: Biologics segment by revenue 2013-2015 ($ millions)
  • Exhibit 41: NuVasive: Key takeaways
  • Exhibit 42: Zimmer Biomet: Product portfolio
  • Exhibit 43: Zimmer Biomet: Key takeaways
  • Exhibit 44: SeaSpine: Product portfolio
  • Exhibit 45: SeaSpine: Orthopedics segment by revenue 2013-2015 ($ millions)
  • Exhibit 46: SeaSpine: Key takeaways
  • Exhibit 47: Other prominent vendors
Back to Top